4.4 Review

Prostate-specific antigen glycoprofiling as diagnostic and prognostic biomarker of prostate cancer

期刊

INTERFACE FOCUS
卷 9, 期 2, 页码 -

出版社

ROYAL SOC
DOI: 10.1098/rsfs.2018.0077

关键词

prostate cancer; diagnostics; biomarkers; lectins; glycans; prostate-specific antigen

类别

资金

  1. Slovak Scientific Grant Agency VEGA [2/0137/18, 2/0090/16]
  2. Slovak Research and Development Agency [APVV 17-0300]
  3. ERC Proof of Concept grant [825586]
  4. Innovative Training Network [813120]
  5. ERDF [26240120007]
  6. European Research Council (ERC) [825586] Funding Source: European Research Council (ERC)

向作者/读者索取更多资源

The initial part of this review details the controversy behind the use of a serological level of prostate-specific antigen (PSA) for the diagnostics of prostate cancer (PCa). Novel biomarkers are in demand for PCa diagnostics, outperforming traditional PSA tests. The review provides a detailed and comprehensive summary that PSA glycoprofiling can effectively solve this problem, thereby considerably reducing the number of unnecessary biopsies. In addition, PSA glycoprofiling can serve as a prognostic PCa biomarker to identify PCa patients with an aggressive form of PCa, avoiding unnecessary further treatments which are significantly life altering (incontinence or impotence).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据